Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/2013
10/15/2013CA2767092C Novel compounds, pharmaceutical compositions containing same and methods of use for same
10/15/2013CA2697256C Cyclopropyl amide derivatives
10/15/2013CA2589951C Method for producing carboxy-terminal amidated peptides
10/15/2013CA2570268C Use of acetyl l-carnitine for the preparation of a medicine for the treatment of neuropathic pain in diabetic patients
10/15/2013CA2529055C Improved absorption of fat-soluble nutrients
10/15/2013CA2515607C Use of lupinus albus conglutin gamma for the treatment of type ii diabetes
10/10/2013WO2013152109A1 Trpv4 antagonist and methods of use thereof
10/10/2013WO2013151923A1 Pyrimidinone carboxamides as inhibitors of endothelial lipase
10/10/2013WO2013151877A1 Pyrimidinedione carboxamide inhibitors of endothelial lipase
10/10/2013WO2013151192A1 Composition comprising eupatorium spp. extract as active ingredient for preventing and treating obesity and metabolic bone disease
10/10/2013WO2013151082A1 Aqueous liquid beverage
10/10/2013WO2013151033A1 C-glycoside derivative having a spiro ring
10/10/2013WO2013150771A1 Composition and method for the safe and effective inhibition of pancreatic lipase in mammals
10/10/2013WO2013150416A1 Diacylglycerol acyltransferase 2 inhibitors
10/10/2013WO2013149977A1 1,2- pyridazine, 1,6- pyridazine or pyrimidine - benzamide derivatives as gpbar1 modulators
10/10/2013WO2013149976A1 Indole-pyrimidine derivatives and their therapeutic uses
10/10/2013WO2013149362A1 1-(dihydronaphthalenyl)pyridones as melanin-concentrating hormone receptor 1 antagonists
10/10/2013WO2013133685A8 Extract formulations of rhodamnia cinerea and uses thereof
10/10/2013WO2013090454A3 Carboxylic acid derivatives comprising four cycles acting as glp-1 receptor modulators for therapy of diseases such as diabetes
10/10/2013US20130267477 Method of using nutritional compounds dihydroquercetin (taxifolin) and arabinogalactan in combination with dihydroquercetin (taxifolin) to reduce and control cardiometabolic risk factors associated with metabolic syndrome and hypercholesterolemia
10/10/2013US20130266553 Albumin Fusion Proteins
10/09/2013EP2647712A2 Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes
10/09/2013EP2647697A1 Method for producing hematopoietic stem cells using pyrazole compound
10/09/2013EP2647634A1 Indole-pyrimidine derivatives and their therapeutic uses
10/09/2013EP2647374A1 Nutritional compositions including beta-hydroxy-beta-methylbutyrate for regulating transcription factors
10/09/2013EP2646471A2 Anti-bradykinin b2 receptor (bkb2r) monoclonal antibody
10/09/2013EP2646444A1 Substituted purine and 7 - deazapurine compounds as modulators of epigenetic enzymes
10/09/2013EP2646429A1 4-substituted-cyclohexylamino-4-piperidinyl-acetamide antagonists of ccr2
10/09/2013EP2646425A1 Indanyloxydihydrobenzofuranylacetic acids
10/09/2013EP2646044A1 Methods for increasing intracellular activity of hsp70
10/09/2013EP2646031A1 Increasing drug bioavailability in naltrexone therapy
10/09/2013EP2646016A1 Treatment of obesity using non-daily administration of 6 - 0 - (4 - dimethylaminoethoxy) cinnamoyl fumagillol
10/09/2013EP2646011A1 Methods for reducing binge or compulsive eating
10/09/2013CN103347870A Crystalline solids of metap-2 inhibitor and method of making and using same
10/09/2013CN103347530A Therapeutic agent and preventive agent for diabetes
10/09/2013CN103347523A Administration of lorcaserin to individual with renal impairment
10/09/2013CN103347508A Methods of treatment using lipid compound
10/09/2013CN103342755A Lycium barbarum polysaccharide homogeneous fraction IV, and preparation method and application thereof
10/09/2013CN103342744A Angiogenesis protein and application thereof
10/09/2013CN103342726A Preparation method and application of camellia flavonoid for reducing blood glucose
10/09/2013CN103342700A 11[beta]-hydroxysteroid dehydrogenase type 1 inhibitor
10/09/2013CN103342695A 1',3'-disubstituted-4-pheny-3,4,5,6-tetrahydro-2H,1'H-[1,4']bipyridinyl-2'-ones
10/09/2013CN103341120A Purely Chinese herbal preparation for reducing blood pressure
10/09/2013CN103341088A Medicine for treating blood sugar type fatty liver
10/09/2013CN103341084A Traditional Chinese medicine preparation for treating simple obesity
10/09/2013CN103341073A Traditional Chinese medicine preparation for treatment of diabetes and preparation method thereof
10/09/2013CN103341070A Externally used medicine for preventing and treating hypertension, hyperlipidemia, hyperglycemia and hypotension and preparation method thereof
10/09/2013CN103341054A Traditional Chinese medicine preparation for treating cardiovascular and cerebrovascular diseases and preparation method thereof
10/09/2013CN103341052A Medicine for preventing and treating hypertension, hyperlipidemia, hyperglycemia and hypotension and preparation method thereof
10/09/2013CN103341035A Radix bupleuri lipid-lowering soup
10/09/2013CN103341015A Medicine for treating three-highs and preparation method thereof
10/09/2013CN103340991A Oral liquid for nursing diabetics and preparation method thereof
10/09/2013CN103340977A Buccal tablet applicable to being taken for type II diabetes
10/09/2013CN103340919A Lucid ganoderma refined powder compound soft capsule and preparation method thereof
10/09/2013CN103340916A Lindley eupatorium extract as well as preparation method and application thereof
10/09/2013CN103340895A Composition containing various microelements, preparation and preparation method thereof
10/09/2013CN103340891A B vitamins containing composition and preparation method thereof
10/09/2013CN103340880A Application of 2,3-dihydroxy benzoic acid ester compound in preparation of foods and medicines for treating diabetes
10/09/2013CN103340879A Medical application of 11-ketoandrostenedione and 11-ketotestosterone
10/09/2013CN103340863A Application of nicotinamide to preparation of drugs for healing diabetic wounds
10/09/2013CN103340853A Compound 18-amino acid injection containing little amount of antioxidant and preparation method thereof
10/09/2013CN103340852A Pharmaceutical composition containing ezetimibe and atorvastatin
10/09/2013CN103340846A Arachidonic acid soft capsule and preparation method
10/09/2013CN103340845A 药物组合物 The pharmaceutical composition of
10/09/2013CN103340844A Application of gamatine in preparing drug resisting high PTH
10/09/2013CN103340404A Drink with health care effect on sexual hypoactivity, deficiency of kidney yin and diabetes
10/09/2013CN103340254A Weight reducing tea
10/09/2013CN102690324B Gynura bicolor protein extract, and preparation method and application thereof
10/09/2013CN102599511B Food therapy prescription for treating diabetes
10/09/2013CN102552814B Traditional Chinese drug for treating diabetes
10/09/2013CN102423352B Preparation method of Chinese medicinal granules for treating cardio-cerebrovascular diseases
10/09/2013CN102421796B Novel exendin variant and conjugate thereof
10/09/2013CN102366428B Applications of extracts from Chinese herbal medicine Oroxylum indicum in preparation of slimming and lipid lowering medicine or preparation of medicine with inhibition effect on activity of lipase
10/09/2013CN102247417B Fat reduction effect of total saponins and polysaccharides of Panax japonicus
10/09/2013CN102247377B Application of carbon drop quinone methyl triterpene in preparation of drug for preventing and treating diabetes
10/09/2013CN102061322B Method for preparing polysaccharide, flavone and dietary fiber of peanut hulls in united manner
10/09/2013CN101801954B Compounds and compositions as modulators of GPR119 activity
10/08/2013US8552196 Apoptosis signal-regulating kinase inhibitors
10/08/2013US8552062 Methods for the treatment of metabolic disorders such as diabetes
10/08/2013US8552054 Anticancer agents, viricides, psychological disorders
10/08/2013US8552040 Isoxazoline compounds having MIF antagonist activity
10/08/2013US8552013 Heterocyclic compounds based on N6-substituted adenine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds
10/08/2013US8551992 Aminooxazole inhibitors of cyclin dependent kinases
10/08/2013US8551945 Methods and compositions for treating neuropathies
10/08/2013US8551944 Methods of treating glucose metabolism disorders
10/08/2013US8551914 Pesticidal compositions
10/08/2013CA2640924C Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
10/08/2013CA2473938C Human adam-10 inhibitors
10/08/2013CA2453403C Methods of inhibiting amyloid toxicity
10/08/2013CA2349839C Ucp5
10/03/2013WO2013149259A1 Method for promoting lipolysis and oxidation in liver and adipose tissue using catestatin
10/03/2013WO2013149258A2 Compositions and methods for treating or preventing metabolic syndrome disorders
10/03/2013WO2013148871A1 Engineered polypeptides
10/03/2013WO2013148579A1 Pegylated c-peptide
10/03/2013WO2013148359A1 High porosity cellulosic sponge
10/03/2013WO2013148333A1 Salicylic acid derivatives useful as glucocerebrosidase activators
10/03/2013WO2013148305A1 Method for treating diabetic retinopathy
10/03/2013WO2013147750A1 Oral combination therapy for treating hcv infection in specific patient sub-population
10/03/2013WO2013147711A1 Bicyclic heterocyclic derivatives as mnk1 and mnk2 modulators and uses thereof
10/03/2013WO2013147618A1 Ionophore antibiotic suspension
1 ... 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 ... 1298